29 November 2022
SHARE NOW
ATW
CAR-X
Cell Therapy
Gene Editing
Gene Therapy
Patient Access & Engagement
Jenny Ligon, Associate Director of Workforce Development at the National Center for Therapeutic Manufacturing (NCTM), Texas U.S., sat down to talk with Phacilitate’s Editor Georgi Makin to ahead of her appearance and presentation at Advanced Therapies Week 2023.
Jenny considers the importance of sharing creative mechanisms for rapid workforce training and development in order to globally grow the biomanufacturing industry – one of the biggest issues currently limiting translational ATMP’s.
Don’t miss Jenny’s session ‘Enhancing Technical Knowledge in CGT: Training Skilled Personnel for the Technical Workforce of the Future’, at ATW23, Thursday 19th January, 2023.
Join us at Advanced Therapies Week >>
More like this
Scalable, xeno-free expansion of mesenchymal stem cells in a fixed-bed bioreactor
This case study showcases the successful expansion of mesenchymal stem cells (MSCs) using Rooster Bio’s xeno-free MSC platform in Univercells Technologies’ scale-X fixed-bed bioreactor. The collaboration highlights seamless process transfer, rapid cell attachment, optimized harvesting with high viability (>96%), and robust scalability from R&D to GMP manufacturing. Key innovations include predictive bioprocess monitoring with Scalia Vision and cost-effective solutions for advanced therapy manufacturing.
19 February 2025
Must-See Sessions at Advanced Therapies Week 2025: Ry Leahy, Head of Content, Phacilitate
Cell and gene therapies are set to revolutionize the future of medicine, but one of the major hurdles is the production of good quality cells cost-effectively and at scale
10 January 2025
